Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-01-25
1995-07-18
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3800
Patent
active
054341353
ABSTRACT:
The invention in growth factor compositions includes: a novel compound which is a separate pure nicked or pure non-nicked species of epidermal growth factor EGF1-48 or its hEGF1-47 or hEGF1-49 congener compound, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition in dosage form comprising an effective amount of the novel compound and/or the known hEGF1-53; and use thereof for treating abnormal cell growth conditions including gastrointestinal/duodenal lesions; and methods of making the pure novel hEGF species. This unique therapeutic utility is enhanced by the unexpected and heretofore unappreciated structural stability and resistance of the pure species to enzymatic degradation.
REFERENCES:
patent: 3883497 (1975-05-01), Gregory et al.
patent: 3917824 (1975-11-01), Camble
patent: 4032633 (1977-06-01), Gregory et al.
patent: 4035485 (1977-07-01), Gregory et al.
patent: 4490365 (1984-12-01), Panaretto et al.
patent: 4528186 (1985-07-01), Nishimura et al.
patent: 4621052 (1986-11-01), Sugimoto
patent: 4686283 (1987-08-01), Nestor, Jr. et al.
patent: 4710473 (1987-12-01), Morris
patent: 4717717 (1988-01-01), Finkehaur
patent: 4719180 (1988-01-01), Eaton et al.
patent: 4731357 (1988-03-01), Franklin et al.
patent: 4743679 (1988-05-01), Cohen et al.
patent: 4760023 (1988-07-01), Miyoshi et al.
patent: 4764593 (1988-08-01), Banks et al.
patent: 4783412 (1988-11-01), Bell
patent: 4820690 (1989-04-01), Gregory et al.
patent: 4849350 (1989-07-01), Yoshio et al.
patent: 4857334 (1989-08-01), Korol et al.
patent: 4863902 (1989-09-01), Amagase et al.
patent: 4870008 (1989-09-01), Brake
patent: 5057494 (1991-10-01), Sheffield
FEBS 3962, vol. 205, No. 1, Sep. 1986, "A High Resolution .sup.1 H NMR Study of the Solution Structure of Human Epidermal Growth Factor", J. A. Carver, et al., pp. 77-81.
Biochemistry, 1988, 27, pp. 4977-4985, "Murine Epidermal Growth Factor: Structure and Function", Antony W. Burgess, et al.
Nature, vol. 327, May 28, 1987, "The Solution Structure of Human Epidermal Growth Factor", Robert M. Cooke, et al., pp. 339-341.
Molecular Pharmacology, vol. 17, No. 3, May 1980, pp. 314-320, Morley D. Hollenberg et al. "Epidermal Growth Factor-Urogastrone: Biological Activity and Receptor Binding of Derivatives".
Patent Abstracts of Japan, vol. 12, No. 306 (C-522) (3153) 19 Aug. 1988 & JP-A-6377823 (Fujisawa Pharmaceutical Co., Ltd.) 8 Apr. 1988.
Amarant Tanchum
Guglietta Antonio
Nardi Ronald
Parikh Indu
Huff Sheela J.
Parikh Indu
Warden Jill
LandOfFree
Growth factor compositions, preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth factor compositions, preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor compositions, preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2419025